(Q80118132)

English

Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder

scientific article published on 01 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

based on heuristic

inferred from title

Shahrokh Shariat

1

object named as

Shahrokh F Shariat

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Raheela Ashfaq

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Arthur I Sagalowsky

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Yair Lotan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

468-475

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Cyclin-dependent regulation of G1 in mammalian fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Cyclin E in human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Deregulated cyclin E induces chromosome instability

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Cyclin E overexpression and amplification in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

A survivin gene signature predicts aggressive tumor behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Survivin, versatile modulation of cell division and apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Survivin expression is associated with features of biologically aggressive prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Cell cycle checkpoints and DNA repair preserve the stability of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Cyclin E and p27/Kip1: two proteins on a see-saw or another false dawn?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.09.011

7 January 2021

Identifiers

10.1016/J.UROLONC.2006.09.011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18047954%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80118132&oldid=2190504291"